About
Non-invasive ultrasound therapy for the treatment of calcific aortic stenosis
Areas of Focus
Categories
Uncategorized Medical Device
Team (21)
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
5
As Collaborator
4
Total Enrollment
1,718
By Phase
NA: 5PHASE3: 1PHASE1: 2
By Status
COMPLETED: 8NOT_YET_RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06650839Lead Sponsor
POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy
NANot yet recruiting
10 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
NCT05235568Lead Sponsor
VALVOSOFT® Pivotal Study
NACompleted
60 participants
Started: Jun 15, 2022 · Completed: Jul 24, 2024
NCT04702451Collaborator
Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
NACompleted
377 participants
Started: Feb 12, 2021 · Completed: Dec 27, 2023
NCT04665596Lead Sponsor
Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis
NACompleted
10 participants
Started: Dec 23, 2019 · Completed: May 23, 2024
NCT04158713Collaborator
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
PHASE3Completed
898 participants
Started: Nov 11, 2019 · Completed: Aug 30, 2022
Locations (1)
Headquarters
Levallois-Perret, France
Map
Loading map...